Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Feasibility of Outpatient Automated Blood Glucose Control With the iLet Bionic Pancreas for Treatment of Cystic Fibrosis Related Diabetes

NCT03258853 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT03258853
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03258853 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Feasibility of Outpatient Automated Blood Glucose Control With the iLet Bionic Pancreas for Treatment of Cystic Fibrosis Related Diabetes
Lead sponsor
Massachusetts General Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 26, 2021
Completion date
June 29, 2022
Enrollment
22 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis-related diabetes